Join to View Full Profile
950 N Mcqueen Rd Ste 100Chandler, AZ 85225
Phone+1 480-542-7000
Fax+1 480-542-7500
Dr. Chilukuri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
SSM Health/Saint Louis University School of MedicineFellowship, Gastroenterology, 2017 - 2020
Indiana University School of MedicineResidency, Internal Medicine, 2014 - 2017
Rush Medical College of Rush University Medical CenterClass of 2014
Certifications & Licensure
AZ State Medical License 2020 - 2026
MO State Medical License 2017 - 2021
IN State Medical License 2016 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 57 citationsRetrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.Joseph Meserve, Satimai Aniwan, Jenna L. Koliani-Pace, Preeti Shashi, A Weiss
Clinical Gastroenterology and Hepatology. 2019-07-01 - 11 citationsExtrahepatic Autoimmune Diseases are Prevalent in Autoimmune Hepatitis Patients and Their First-Degree Relatives: Survey StudyRachel Fogel, Megan Comerford, Prianka Chilukuri, Eric S. Orman, Naga Chalasani
Interactive Journal of Medical Research. 2018-12-19 - 53 citationsPredictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, Prianka Chilukuri, Joseph Meserve
Inflammatory Bowel Diseases. 2018-10-12
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
